# A Tailored Phospho‐p53 Library Probes Antibody Specificity and Recognition Limitations

**Authors:** Mateusz Hess, Jonathan H. Davies, Sofia Margiola, Sonja Schneider, Thomas Hicks, Nishant Rai, Manuel M. Müller

PMC · DOI: 10.1002/cbic.202500256 · 2025-06-23

## TL;DR

Researchers created a library of phosphorylated p53 proteins to test antibody specificity and found that phosphorylation can hide antibody binding sites.

## Contribution

A tailored library of site-specifically phosphorylated p53 proteins was developed to probe antibody recognition and epitope masking.

## Key findings

- The study validated the specificity of phosphorylation-specific anti-p53 antibodies.
- Phosphorylation was found to cause widespread epitope masking in commonly used antibodies.

## Abstract

The tumor suppressor protein p53, known as the “guardian of the genome,” is regulated by a complex network of post‐translational modifications. Phosphorylations at 7 Ser/Thr residues within the N‐terminal transactivation domain 1 (TAD1) play a role in p53 activation, yet their precise mechanisms of action remain elusive due to challenges in accessing well‐defined phosphorylated isoforms. To address this limitation, this study harnesses a recently developed approach for the semisynthesis of site‐specifically phosphorylated p53 to generate a comprehensive library of singly phosphorylated p53 including all TAD1 sites: Ser6, Ser9, Ser15, Thr18, Ser20, Ser33, and Ser37. The library was then used to probe the specificity of common p53 antibodies in western blot analysis. This study's results confirm the specificity of the target site of most phosphorylation‐specific anti‐p53 antibodies, but also reveal wide‐spread epitope masking by phosphorylation, which has implications for p53 research and diagnostics. This "designer" p53 library thus provides a toolkit to study the function of p53 phosphorylation directly and indirectly as a quality control agent for some of the most widely used reagents in the field.

Site‐specifically phosphorylated isoforms of the tumor suppressor p53 – encompassing all seven known phosphorylation sites within the TAD1 domain –are created upon optimization of semisynthesis protocols. This “designer" p53 library enabled validation of phosphorylation‐specific p53 antibodies and revealed epitope masking by phosphorylation in commonly used antibodies.© 2025 WILEY‐VCH GmbH

## Linked entities

- **Genes:** TP53 (tumor protein p53) [NCBI Gene 7157]
- **Proteins:** TP53 (tumor protein p53)

## Full-text entities

- **Genes:** TP53 (tumor protein p53) [NCBI Gene 7157] {aka BCC7, BMFS5, LFS1, P53, TRP53}
- **Diseases:** tumor (MESH:D009369)
- **Chemicals:** Phospho- (-), Ser (MESH:D012694)

## Figures

50 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12278346/full.md

---
Source: https://tomesphere.com/paper/PMC12278346